Ocuphire Pharma Inc. buy Alliance Global Partners
Start price
20.03.24
/
50%
€1.84
Target price
20.03.25
€18.44
Performance (%)
-20.70%
Price
29.04.24
€1.55
Summary
This prediction is currently active. The price of Ocuphire Pharma Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -20.70%. This prediction currently runs until 20.03.25. The prediction end date can be changed by Alliance_Global_Part at any time. Alliance_Global_Part has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Ocuphire Pharma Inc. | 9.477% | 9.477% |
iShares Core DAX® | -1.370% | -3.231% |
iShares Nasdaq 100 | 0.172% | -3.339% |
iShares Nikkei 225® | -0.801% | -7.859% |
iShares S&P 500 | -0.369% | -2.979% |
Comments by Alliance_Global_Part for this prediction
In the thread Ocuphire Pharma Inc. diskutieren
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its price target lowered by analysts at Alliance Global Partners from $24.00 to $20.00. They now have a "buy" rating on the stock.
Ratings data for OCUP provided by MarketBeat